🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07144722
Starting soon Not applicable

Prehabilitation Program for Patients Awaiting Elective Heart Surgery at Increased Risk of Postoperative Complications: Feasibility and Potential Clinical Outcomes

NCT07144722 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2025-09-15
Last updated
2025-08-27

Condition(s) studied

Cardiac SurgeryPrehabilitationPostoperative Complications

Investigational drug(s) / intervention(s)

Exercise

Exercise: What distinguishes this intervention from others is its hybrid delivery model, combining virtual more than in-person sessions to increase accessibility and adherence. Additionally, it incorporates specific inspiratory muscle training, which is often overlooked in standard prehabilitation programs, and emphasizes a personalized progression based on each participant's functional capacity and feedback. This tailored approach aims to optimize physical readiness before surgery while minimizing patient burden and travel requirements.

Study summary

The goal of this study is to learn if an exercise-based prehabilitation program can help people who are waiting for heart surgery and are at higher risk of complications recover better.

The main questions it aims to answer are:

Can a home-based prehabilitation program prescribed by a physiotherapist be done safely and realistically before heart surgery?

Participants will:

Take part in a personalized exercise program for a 8 to 16 weeks before surgery

Do breathing muscle training at home

Meet with a physiotherapist once a week, either in person or by video call

Be assessed before and after the program

Researchers will compare the postoperative results with those of patients who received usual care only.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * A high risk of perioperative and postoperative complications. This risk is determined based on the predictive thresholds for postoperative complications. * A waiting period of at least 8 weeks. * Access to a smartphone, tablet, or computer for videoconference visits. Exclusion Criteria: * Unstable angina, malignant arrhythmias, active endocarditis/myocarditis, myocardial infarction within the last 2 weeks, left main coronary artery disease ≥ 50% on coronary angiography, severe aortic stenosis, severe mitral insufficiency, and decompensated heart failure. * Any other acute condition affecting vital signs or causing significant symptoms. * Physical or cognitive impairment limiting the ability to participate in the program.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Montreal Heart Institut Montreal Quebec

More Montreal Heart Institute trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07144722 on ClinicalTrials.gov ↗ ← All trials in Canada